Candida spp. Bloodstream infection: Influence of antifungal treatment on outcome

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 3, 2010, Pages 562-568

  Ortega, M ^a   Marco, F ^a   Soriano, A ^a   Almela, M ^a   Martinez J A ^a   Pitart, C ^a   Mensa, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Candidaemia; Echinocandins; Mortality; Triazoles

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CORTICOSTEROID; ECHINOCANDIN; FLUCONAZOLE; TRIAZOLE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA TROPICALIS; CANDIDEMIA; CHRONIC KIDNEY FAILURE; CLAVISPORA LUSITANIAE; COMORBIDITY; DIABETES MELLITUS; DISEASE SURVEILLANCE; FEMALE; FUNGAL STRAIN; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KLUYVEROMYCES MARXIANUS; LIFE EXPECTANCY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PICHIA GUILLIERMONDII; SOLID TUMOR; SPECIES DIFFERENCE;

ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDIASIS; DRUG THERAPY, COMBINATION; ECHINOCANDINS; FEMALE; FUNGEMIA; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRIAZOLES;

EID: 77950327388     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp495     Document Type: Article

References (11)

1. Rex JH, Bennet JE, Sugar AM et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidaemia in patients without neutropenia. N Engl J Med 1994; 331: 1325-30.
2. Mora-Duarte J, Betts R, Rotstein C et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347: 2020-9.
3. Reboli AC, Rotstein C, Pappas PG et al. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 2007; 356: 2472-82.
4. Kuse ER, Chetchotisakd P, da Cunha CA et al. Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 2007; 369: 1519-27.
5. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35.
6. Clinical Laboratory and Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts-Third Edition: Approved Standard M27-A3. CLSI, Wayne, PA, USA, 2008.
7. Annane D, Bellisant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78.
8. Blot F, Nitenberg G, Brun-Buisson C. New tools in diagnosing catheter-related infections. Support Care Cancer 2000; 8: 287-92.
9. Raad I, Hanna HA, Alakech B et al. Differential time to positivity: a useful method for diagnosing catheter-related infections. Ann Intern Med 2004; 140: 18-25.
10. McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962; 110: 847-55.
11. Cappelletty D, Eiselstein-McKitrick K. The echinocandins. Pharmacotherapy 2007; 27: 369-88.